Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. STZ
3. APLD
4. CRGY
5. RMR
6. PEP
7. DVN
8. ANGO
9. LULU
10. SPCX

Go back to Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results

Inovio Pharmaceuticals (INO) PT Raised to $14 at RBC Capital

March 15, 2018 8:25 AM EDT

RBC Capital raised its price target on Inovio Pharmaceuticals (NASDAQ: INO) to $14.00 (from $11.00) while maintaining an Outperform rating.

Analyst Gregory Renza notes the pipeline continues to progress as VGX-3100 continues to ramp up with broad CIN site expansion.

... More